These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17197828)

  • 1. Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion.
    Terzi R; Niero F; Iemoli E; Capetti A; Coen M; Rizzardini G
    AIDS; 2007 Jan; 21(2):262-3. PubMed ID: 17197828
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
    Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
    Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PEP or no PEP? The rational of initiating postexposure prophylaxis].
    El Amari EB; Iten A; Sacroug T; Hirschel B
    Rev Med Suisse; 2008 Apr; 4(152):894-5, 899-900. PubMed ID: 18578429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
    Danta M; Brown D; Bhagani S; Pybus OG; Sabin CA; Nelson M; Fisher M; Johnson AM; Dusheiko GM;
    AIDS; 2007 May; 21(8):983-91. PubMed ID: 17457092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infections. Can hepatitis C virus help keep cholesterol levels low?
    TreatmentUpdate; 2006; 18(5):4-5. PubMed ID: 17205648
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of HIV seroconversion among men who have sex with men living in a low HIV incidence population in the era of highly active antiretroviral therapies.
    Lavoie E; Alary M; Remis RS; Otis J; Vincelette J; Turmel B; Lavoie R; Masse BR; Le Clerc R
    Sex Transm Dis; 2008 Jan; 35(1):25-9. PubMed ID: 17898678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 13. Postexposure prophylaxis after sexual exposure to HIV.
    Roland ME
    Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates.
    Gruber SA; Doshi MD; Cincotta E; Brown KL; Singh A; Morawski K; Alangaden G; Chandrasekar P; Losanoff JE; West MS; El-Amm JM
    Transplantation; 2008 Jul; 86(2):269-74. PubMed ID: 18645490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/hepatitis co-infection.
    Rockstroh J
    J HIV Ther; 2007 Mar; 12(1):1. PubMed ID: 17589388
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infections. Some good news about HAART and liver health.
    TreatmentUpdate; 2008; 20(4):8. PubMed ID: 19248274
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.